Skip to content
★ Sign in to follow
DG

Daniel Grau

EPIRUS Biopharmaceuticals, Inc.
Total declarations
24
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€228k

Latest filing published 29 Jan 2008 for EPIRUS Biopharmaceuticals, Inc., €56k.

Insider track record

Disclosed buys
0
Disclosed sells
13
Signal history

No signal scores available.

Daniel Grau: trading record in brief

Daniel Grau is a declared insider of EPIRUS Biopharmaceuticals, Inc., with filings sourced from SEC (Form 4). Between 26 January 2006 and 26 January 2008, the trades on record add up to 24 filings.

Sales make up the whole of the open-market record (13 sales, €228k). Other entries cover 2 share grants and 9 option exercises.

On 29 January 2008 came the latest disclosure, a share grant for €56k in EPIRUS Biopharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Daniel Grau

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total

24 of 24 declarations